Authors: Kontoghiorghes, GJ Agarwal, MB Tondury, P Marx, JJM

Citation: Gj. Kontoghiorghes et al., Deferiprone or fatal iron toxic effects?, LANCET, 357(9259), 2001, pp. 882-883

Authors: Kontoghiorghes, GJ

Citation: Gj. Kontoghiorghes, Clinical use, therapeutic aspects and future potential of deferiprone in thalassemia and other conditions of iron and other metal toxicity, DRUGS TODAY, 37(1), 2001, pp. 23-35

Authors: Kontoghiorghes, GJ Pattichi, K Hadjigavriel, M Kolnagou, A

Citation: Gj. Kontoghiorghes et al., Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1), TRANSFUS SC, 23(3), 2000, pp. 211-223

Authors: Kontoghiorghes, GJ Agarwal, MB Grady, RW Koinagou, A Marx, JJ

Citation: Gj. Kontoghiorghes et al., Deferiprone for thalassaemia, LANCET, 356(9227), 2000, pp. 428-429

Authors: Pashalidis, I Kontoghiorghes, GJ

Citation: I. Pashalidis et Gj. Kontoghiorghes, Effective complex formation in the interaction of 1,2-dimethyl-3-hydroxypyrid-4-one (Deferiprone or L1) with uranium(VI), J RAD NUCL, 242(1), 1999, pp. 181-184